Cost-effectiveness of RAMP-HT for Patients With Uncontrolled Hypertension in Hong Kong

CompletedOBSERVATIONAL
Enrollment

158,322

Participants

Timeline

Start Date

August 1, 2016

Primary Completion Date

January 31, 2019

Study Completion Date

January 31, 2019

Conditions
HypertensionCost Effectiveness
Interventions
OTHER

RAMP-HT

RAMP-HT was launched since October 2011 by the Hospital Authority with the support from the Food and Health Bureau. Standardized cardiovascular risk factor assessment, hypertensive complication screening and assessment on patient adherence to treatment are carried out on enrolled patients. Patients are stratified into low, medium or high risk groups according to the 10-year cardiovascular disease (CVD) risk calculated from their relevant risk factors by the Joint British Society 2005 Equation. A multidisciplinary team comprised of doctors, nurses, dieticians, physiotherapists and/or occupational therapists would then deliver individualized management targeted to the patient's risk factors according to standardized risk-stratified guidelines.

Trial Locations (1)

Unknown

The University of Hong Kong, Hong Kong

All Listed Sponsors
lead

The University of Hong Kong

OTHER

NCT03301194 - Cost-effectiveness of RAMP-HT for Patients With Uncontrolled Hypertension in Hong Kong | Biotech Hunter | Biotech Hunter